Cargando…

The role of the TRAF2/3 binding site in LMP1 and CD40 signaling

Detalles Bibliográficos
Autores principales:	Graham, JP, Bishop, GA
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2009
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4261774/ http://dx.doi.org/10.1186/1750-9378-4-S2-P19

Ejemplares similares

Requirement for TRAF3 in Signaling by LMP1 But Not CD40 in B Lymphocytes
por: Xie, Ping, et al.
Publicado: (2004)

Roles of the Kinase TAK1 in TRAF6-Dependent Signaling by CD40 and Its Oncogenic Viral Mimic, LMP1
por: Arcipowski, Kelly M., et al.
Publicado: (2012)

Differential Signaling and Tumor Necrosis Factor Receptor–Associated Factor (Traf) Degradation Mediated by Cd40 and the Epstein-Barr Virus Oncoprotein Latent Membrane Protein 1 (Lmp1)
por: Brown, Kevin D., et al.
Publicado: (2001)

TRAF5-mediated Tax ubiquitination modulates IKK phosphorylation but not binding to NEMO
por: Bonnet, Amandine, et al.
Publicado: (2014)

Exosomal sorting of the viral oncoprotein LMP1 is restrained by TRAF2 association at signalling endosomes
por: Verweij, Frederik J., et al.
Publicado: (2015)

Role of CD40 ligand in transfusion-related acute lung injury
por: Tuinman, PR, et al.
Publicado: (2011)

The role of CD26 and CD40 expression in therapeutic response - experimental study in oral cancer lines
por: Batista, Joana PN, et al.
Publicado: (2010)

Role of CD40(L)-TRAF signaling in inflammation and resolution—a double-edged sword
por: Strohm, Lea, et al.
Publicado: (2022)

Multimeric forms of CD40 ligand (CD40L), 4-1BB ligand (4-1BBL), OX40 ligand (OX40L), CD27L/CD70, and other TNFSFs as tools for adoptive cell therapy
por: Kornbluth, Richard S
Publicado: (2013)

Targeting CD40-Induced TRAF6 Signaling in Macrophages Reduces Atherosclerosis
por: Seijkens, Tom T.P., et al.
Publicado: (2018)

Identification of human mutations in TRAF3IP1 in patients with nephronophthisis and retinal degeneration
por: Becker-Heck, A, et al.
Publicado: (2015)

P05-05. Enhanced immunogenicity of HIV-1 envelope glycoprotein trimers fused to CD40 ligand
por: Melchers, M, et al.
Publicado: (2009)

30-bp deletion variant of LMP-1 gene of EBV in HIV+ patients After several years of antiretroviral therapy
por: Cherot, Janine, et al.
Publicado: (2006)

The human CD40 agonistic antibody ADC-1013 generates immune mediated anti-tumor effects in syngeneic tumor models in hCD40 transgenic mice
por: Mangsbo, Sara M, et al.
Publicado: (2014)

Hyperglycosylated resurfaced stabilized GP120 core as an immunogen elicits antibodies targeted at the CD4-binding site
por: Dai, K, et al.
Publicado: (2012)

Bystander memory CD8 T cell proliferation after anti-CD40/IL-2 treatment is independent of CD4 T cells
por: Grossenbacher, Steven K, et al.
Publicado: (2013)

CD40L is selectively expressed on platelets from thrombocytopenic septic patients
por: Montalbano, AM, et al.
Publicado: (2010)

ADC-1013, an agonistic CD40 antibody optimized for local immunotherapy of cancer
por: Mangsbo, Sara M, et al.
Publicado: (2013)

Pre-clinical development of the human CD40 agonistic antibody ADC-1013
por: Norlén, Per, et al.
Publicado: (2015)

TRAF1 Coordinates Polyubiquitin Signaling to Enhance Epstein-Barr Virus LMP1-Mediated Growth and Survival Pathway Activation
por: Greenfeld, Hannah, et al.
Publicado: (2015)

TRAF1/C5 locus is associated with response to anti-TNF in rheumatoid arthritis
por: Canhão, Helena, et al.
Publicado: (2012)

SiteHopper - a unique tool for binding site comparison
por: Batista, Jose, et al.
Publicado: (2014)

CD40 expression in renal cell carcinoma correlates with tumor apoptosis, CD8 T cell frequency and patient survival
por: Weiss, Jonathan M, et al.
Publicado: (2013)

The TRAF1/C5 region is a risk factor for polyarthritis in juvenile idiopathic arthritis
por: Albers, HM, et al.
Publicado: (2008)

Hyperglycosylated gp120 mutants elicit improved CD4-binding site directed antibodies in a heterologous prime:boost regimen
por: Ahmed, FK, et al.
Publicado: (2012)

Structural definition for a new modality of broad and potent antibody neutralization at the CD4-binding site on HIV-1 gp120
por: Zhou, T, et al.
Publicado: (2012)

A novel role for C-terminal binding proteins in the regulation of mitotic fidelity in breast cancer cells
por: Bergman, LM, et al.
Publicado: (2008)

CD40 Upregulation in the Retina of Patients With Diabetic Retinopathy: Association With TRAF2/TRAF6 Upregulation and Inflammatory Molecule Expression
por: Vos, Sarah, et al.
Publicado: (2023)

P02-06. The adjuvancy of OX40 ligand (CD252) on an HIV-1 canarypox vaccine
por: Liu, J, et al.
Publicado: (2009)

TRAF3 Regulates Homeostasis of CD8(+) Central Memory T Cells
por: Yi, Zuoan, et al.
Publicado: (2014)

Role of miRNA binding site SNPs in candidate genes in a North Indian schizophrenia cohort
por: John, Jibin, et al.
Publicado: (2014)

Induction of potent systemic anti-melanoma immunity through intratumoral CD40 activation and checkpoint blockade
por: Singh, Manisha, et al.
Publicado: (2015)

The CD40 agonistic monoclonal antibody APX005M has potent immune stimulatory capabilities
por: Bjorck, Pia, et al.
Publicado: (2015)

MyD88/CD40-based inducible co-stimulation to improve CAR T cell therapy
por: Mata, Melinda, et al.
Publicado: (2015)

CD40 expression in the hippocampus and its role in blood-brain barrier permeability, neutrophil infiltration and oxidative stress: implication for brain damage associated with sepsis in rats
por: Michels, Monique, et al.
Publicado: (2013)

A CD4/Foxp3/OX40 triple immunofluorescence assay determines association between T cell immune subsets and outcome in colorectal cancer
por: Ziai, James, et al.
Publicado: (2014)

P1378: CAR-T CELLS TARGETING CD38 AND LMP1 EXHIBIT ROBUST ANTI-TUMOR ACTIVITY AGAINST NK/T-CELL LYMPHOMA
por: Hongwen, LI, et al.
Publicado: (2023)

Reproducing indolent B-cell lymphoma transformation with T-cell immunosuppression in LMP1/CD40-expressing mice
por: Vincent-Fabert, Christelle, et al.
Publicado: (2019)

P17-04. Targeting HIV peptides to human dendritic cells via CD40 elicits expansion of multi-epitope polyfunctional CD4+ and CD8+ T cells in HIV patients
por: Flamar, A, et al.
Publicado: (2009)

P09-06. HIV-1 escape from broadly neutralizing anti-CD4 binding site NAbs during HIV-1 infection
por: Sather, D, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_epbsk1lq2jje2et6jr03pigv4q